Navigation Links
First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
Date:5/24/2011

MIAMI BEACH, Fla., May 24, 2011 /PRNewswire/ -- Benefiting from recent investments in production and enormous demand for its products, Divine Skin Inc. (DSKX), just reported another record quarter. The leading developer of topical biotechnology for hair growth posted Q1 sales of $2.25 million, up 126 percent over Q1 of 2010. It was the fastest growth since the company went public just over a year ago.

"Although Q1 delivered a stellar number — made possible by numerous improvements in logistics and fulfillment — we are not yet satisfied and certainly not resting on our accomplishments," said CEO Daniel Khesin. "Divine Skin can grow even faster, and coming quarters will be proof of that."

The company's best-selling shampoo and hair-growth treatments target androgenic alopecia, the most common type of hair loss, which afflicts almost 50 percent of white men over age 40.

"We have just scratched the surface of this enormous market; the potential is endless. With the four new distribution agreements just announced, I have no doubt that shareholders will be enormously satisfied for many years to come."

Khesin was referring to new agreements to sell the DS Laboratories line via four major distributors that supply 27,000 salons and beauty professionals around the United States:

  • Salon Services & Supplies, near Seattle, sells to 10,000 salons in Oregon, Idaho, Washington, and Utah.
  • Sweis, in Torrance, Calif., works with 7,000 salons and licensed professionals around Southern California and Las Vegas.
  • The Salon Center, of Birmingham, Ala., serves 7,000 salons in Florida, Georgia, Alabama, Louisiana, and Mississippi.
  • Salon Only Sales, in River Falls, Wis., serves 3,000 salons in Wisconsin, Minnesota, and Iowa.

The new deals were due largely to Robin Powell, the industry veteran who joined Divine Skin in January as head of global business devel
'/>"/>

SOURCE Divine Skin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
2. Trubion Announces Dates for First-Quarter 2009 Earnings Conference Call
3. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
4. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
5. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
6. China-Biotics Receives First U.S. Sales Order
7. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
8. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
9. Photonic Products Group, Inc. Announces New Sales and Marketing VP
10. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
11. Content Management and Life Sciences Software Veteran Joins Virtify as Vice President of Worldwide Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 AACC welcomed thousands of ... AACC Annual Meeting & Clinical Lab Expo in ... The meeting showcased revolutionary advancements in clinical testing ... healthcare providers to diagnose patients quickly and accurately ... As of Wednesday, July 29, ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Vieillard as Sales & Marketing Director. , With more than 25 years ... responsible for reinforcing Tronics’ business development activities worldwide. He brings to the company ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... , NEW YORK, Dec. 8 ... report is available in its catalogue: , ... , http://www.reportlinker.com/p0164353/Biotechnology-Instrumentation---International-Market-Trends.html , Demand for ... the pharmaceutical industry, proteomics, genomics, functional genomics and ...
... Dec. 8 Vivakor, Inc. (OTC Bulletin Board: VIVK) today ... 1, 2009 will receive the dividend of shares of common ... Board of Directors. HealthAmerica is a private Nevada corporation of ... on the record date. The distribution date will be December ...
... , ROTTERDAM, The ... on reducing prostate cancer,mortality has been given a boost with ... Cancer (ERSPC). This shows the true impact to,be far higher ... Preliminary ERSPC findings* showed that screening reduced prostate ...
Cached Biology Technology:Reportlinker Adds Biotechnology Instrumentation - International Market Trends 2Reportlinker Adds Biotechnology Instrumentation - International Market Trends 3Reportlinker Adds Biotechnology Instrumentation - International Market Trends 4Reportlinker Adds Biotechnology Instrumentation - International Market Trends 5Reportlinker Adds Biotechnology Instrumentation - International Market Trends 6Reportlinker Adds Biotechnology Instrumentation - International Market Trends 7Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31% 2
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... and VIENNA, Nov. 1, 2012 BiOptix today announced that ... commercially available SPR instrument to incorporate phase-based common path interferometry ... Amsterdam from November 1 - 3 as well as at ... 8.  "At the Label Free and PEGS ...
... the rise due to changing diets in emerging economies, ... scientists and institutions in hopes of mitigating the problem. ... experts to further secure its domestic food supply from ... chain disruptions. Food security and nutrition research are ...
... March, the director-general of the World Health Organization warned ... it." In the not-too-distant future, said Margaret Chan, "Things ... knee could once again kill." , The culprit: the ... drugs, a phenomenon known as antibiotic resistance. Chan singled ...
Cached Biology News:BiOptix to highlight new 404pi instrument at European symposia 2Malaysia to battle 'nutrition transition' problem emerging worldwide: More income, poorer diet choices 2Malaysia to battle 'nutrition transition' problem emerging worldwide: More income, poorer diet choices 3Malaysia to battle 'nutrition transition' problem emerging worldwide: More income, poorer diet choices 4Malaysia to battle 'nutrition transition' problem emerging worldwide: More income, poorer diet choices 5Malaysia to battle 'nutrition transition' problem emerging worldwide: More income, poorer diet choices 6WSU researcher to study ecology of antibiotic resistance 2
... Myeloblastosis Virus Reverse Transcriptase (AMV RT) catalyzes ... RNA or RNA:DNA hybrids (1). It requires ... than RNA primers) as well as Mg2+ ... RNase H activity. Both nonionic detergents and ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... RNase-Free DNase is a preparation of ... double-stranded DNA to produce 3-hydroxyl oligonucleotides. ... in applications where maintaining the integrity ... is qualified for use with the ...
... Liquid. In 100 mM KCl, 20 ... 20% glycerol, pH 7.9. AVOID FREEZE/THAW CYCLES. Human ... protein of 765 amino acids encoded by a ... positive and negative supercoiled DNAs without the requirement ...
Biology Products: